Literature DB >> 20652681

Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure.

Joerg C Schefold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20652681     DOI： 10.1007/s00134-010-1965-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  19 in total

1.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.

Authors:  Wolf-Dietrich Döcke; Conny Höflich; Kenneth A Davis; Karsten Röttgers; Christian Meisel; Paul Kiefer; Stefan U Weber; Monika Hedwig-Geissing; Ernst Kreuzfelder; Peter Tschentscher; Thomas Nebe; Andrea Engel; Guillaume Monneret; Andreas Spittler; Kathrin Schmolke; Petra Reinke; Hans-Dieter Volk; Dagmar Kunz
Journal:  Clin Chem       Date:  2005-10-07       Impact factor: 8.327

3.  Consider delayed immunosuppression into the concept of sepsis.

Authors:  Joerg C Schefold; Dietrich Hasper; Petra Reinke; Guillaume Monneret; Hans-Dieter Volk
Journal:  Crit Care Med       Date:  2008-11       Impact factor: 7.598

4.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.

Authors:  Caroline Landelle; Alain Lepape; Nicolas Voirin; Eve Tognet; Fabienne Venet; Julien Bohé; Philippe Vanhems; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

5.  Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.

Authors:  Anne-Claire Lukaszewicz; Marion Grienay; Matthieu Resche-Rigon; Romain Pirracchio; Valérie Faivre; Bernadette Boval; Didier Payen
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

6.  Sepsis: time has come to focus on the later stages.

Authors:  Joerg Christian Schefold; Dietrich Hasper; Hans Dieter Volk; Petra Reinke
Journal:  Med Hypotheses       Date:  2008-04-29       Impact factor: 1.538

Review 7.  Sepsis: time to reconsider the concept.

Authors:  Jean Carlet; Jonathan Cohen; Thierry Calandra; Steven M Opal; Henry Masur
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

8.  A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a.

Authors:  Joerg C Schefold; Stephan von Haehling; Malte Corsepius; Cosima Pohle; Peter Kruschke; Heidrun Zuckermann; Hans-Dieter Volk; Petra Reinke
Journal:  Shock       Date:  2007-10       Impact factor: 3.454

9.  Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to the monitoring of patients with septic shock.

Authors:  Guillaume Monneret; Nadia Elmenkouri; Julien Bohe; Anne-Lise Debard; Marie-Claude Gutowski; Jacques Bienvenu; Alain Lepape
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

10.  Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock.

Authors:  Vincent Caille; Jean-Daniel Chiche; Noureddine Nciri; Christine Berton; Sébastien Gibot; Bernadette Boval; Didier Payen; Jean-Paul Mira; Alexandre Mebazaa
Journal:  Shock       Date:  2004-12       Impact factor: 3.454
View more
  27 in total

1.  Life ain't no SOFA-considerations after yet another failed clinical sepsis trial.

Authors:  David Berger; Joerg C Schefold
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

2.  Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.

Authors:  Thibaud Spinetti; Cedric Hirzel; Michaela Fux; Laura N Walti; Patrick Schober; Frank Stueber; Markus M Luedi; Joerg C Schefold
Journal:  Anesth Analg       Date:  2020-06-04       Impact factor: 5.108

3.  HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma.

Authors:  Qi Yao; Xinqi Ge; Zhichao Lu; Jinlong Shi; Jianhong Shen; Jian Chen
Journal:  J Oncol       Date:  2022-07-12       Impact factor: 4.501

Review 4.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

5.  CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.

Authors:  Tao Wang; Zhi-qin Wang; Lv Wang; Li Yan; Jian Wan; Sheng Zhang; Hong-quan Jiang; Wen-fang Li; Zhao-fen Lin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

6.  Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock.

Authors:  Joerg C Schefold
Journal:  Crit Care       Date:  2011-03-31       Impact factor: 9.097

Review 7.  Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.

Authors:  Lulong Bo; Fei Wang; Jiali Zhu; Jinbao Li; Xiaoming Deng
Journal:  Crit Care       Date:  2011-02-10       Impact factor: 9.097

8.  Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis.

Authors:  Jian-Feng Wu; Jie Ma; Juan Chen; Bin Ou-Yang; Min-Ying Chen; Li-Fen Li; Yong-Jun Liu; Ai-Hua Lin; Xiang-Dong Guan
Journal:  Crit Care       Date:  2011-09-20       Impact factor: 9.097

9.  Protective effect of Flt3L on organ structure during advanced multiorgan dysfunction syndrome in mice.

Authors:  Guang Tian; Jiangyang Lu; Huiqin Guo; Qian Liu; Hongwei Wang
Journal:  Mol Med Rep       Date:  2015-02-10       Impact factor: 2.952

10.  The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.

Authors:  Jianfeng Wu; Lixin Zhou; Jiyun Liu; Gang Ma; Qiuye Kou; Zhijie He; Juan Chen; Bin Ou-Yang; Minying Chen; Yinan Li; Xiaoqin Wu; Baochun Gu; Lei Chen; Zijun Zou; Xinhua Qiang; Yuanyuan Chen; Aihua Lin; Guanrong Zhang; Xiangdong Guan
Journal:  Crit Care       Date:  2013-01-17       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.